FDA Okays Bryan Cervical Disc
The US Food and Drug Administration (FDA) has approved a novel artificial cervical disc, BRYAN, for the treatment of single-level cervical disc diseases like radiculopathy and/or myelopathy. The titanium-polyurethane disc, developed by Medtronic Inc, is implanted in milled pockets of adjacent vertebral bodies from C3-C7 to substitute a diseased or bulging natural cervical disc.
- Interventional Spine(R), Inc. Announces The Completion Of Another Successful Cervical Surgery, With Its PERPOS(R) Percutaneous Cervical System
- DiscAssist gets CE Mark certification
- Pioneer Surgical’s nanOss cervical cage implanted successfully
- FDA Concerned with Cancer Rates for New Spine Device
